Miss Victoria Miari
BSc MSc PgDip
Principal Scientific Officer
& Clinical Scientist
Trained and HCPC registered Clinical Scientist in Microbiology, with a specialist interest in Sexually Transmitted Infections. Has been involved in various research studies including HSV, syphilis and gonorrhoea. A particular interest is antimicrobial resistance in STIs and specifically Neisseria gonorrhoeae. Received B.Sc. in Infectious Diseases from the University of East London and subsequently gained an M.Sc. in Clinical Microbiology by Queen Mary University of London and Pg.Dip. in Sexual Health by Glasgow Caledonian University. Was accepted in the competitive clinical scientist training programme with the British National Health Service and as part of this, sat the FRCPath Part 1 examination in Clinical Microbiology.
- Medical Microbiology
- Control of Infectious Diseases
- Infectious Diseases (DL)
- Core bacteriology & Virology
- Clinical Bacteriology 1 & 2 (Deputy MO)
- Clinical Virology (Deputy MO)
- Antimicrobial Chemotherapy
- Bacterial Infections (DL - Deputy MO)
She leads the Core Bacteriology and Core Virology module practical teaching for the MSc in Medical Microbiology and supports practical classes for clinical bacteriology, clinical virology and mycology modules. She also the deputy module organiser for the Clinical Virology, Clinical Bacteriology 1& 2 and DL Bacterial Infections modules.
She also delivers lectures in the Core Bacteriology and Clinical Bacteriology modules. She regularly supervises MSc project students.
- 2013-2014: Multisite Neisseria gonorrhoeae infection and antimicrobial resistance
- 2014-2015: Optimisation of broth culture for Neisseria gonorrhoeae and gene transfer from commensal Neisserias
- 2016-2017: Understanding the mechanism of resistance for the novel antimicrobial closthioamide in Neisseria gonorrhoeae
Research interests: Clinical diagnostics, Antimicrobial resistance, Sexually Transmitted Infections, Neisseria gonorrhoeae, Pharyngeal gonorrhoea, AMR surveillance, Health Services Research.
Victoria’s research focuses on antimicrobial resistant gonorrhoea and how pharyngeal infection facilitates development and transmission of AMR. Specifically she is interested in the role of commensal species in the genetic transfer of AMR genes, as well as the evaluation novel treatments for gonorrhoea such as topical antiseptics.
She is now evaluating the in vitro efficacy of chlorhexidine against N. gonorrhoeae with the view to implement chlorhexidine containing solutions as gonococcal treatment, thereby improving antimicrobial stewardship.
As part of her expertise in diagnostics, antimicrobial susceptibility testing and public health, she is also interested in multi-site gonorrhoea infection and how that impacts on the above areas. She has found that ina small cohort of male and female patietns with multi-site gonorrhoea, 16% of these patients carried different strains in the different sites.